Lamotrigine Aurobindo

Lamotrigine, the active ingredient in Lamotrigine Aurobindo, is an antiepileptic presented as a tablet for oral use. It is indicated for the treatment of various seizure types and for maintenance therapy in bipolar I disorder. GNH USA supplies Lamotrigine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an antiepileptic medication used to manage seizure disorders and mood stabilization. - Partial seizures: reduces seizure frequency in patients with focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. - Lennox‑Gastaut syndrome: decreases seizure burden in this severe childhood epilepsy. - Bipolar I disorder (maintenance therapy): stabilizes mood and lowers risk of manic or depressive episodes.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Rash or skin irritation. - Headache. - Dizziness or vertigo. - Nausea or gastrointestinal discomfort.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe hypersensitivity reactions including fever and organ involvement. - Hematologic abnormalities such as aplastic anemia or agranulocytosis.

Before initiating lamotrigine therapy, consider the following safety measures. - Monitor skin reactions: discontinue if rash progresses or is severe. - Assess hepatic function: adjust use in patients with liver impairment. - Review concomitant medications: enzyme inducers or inhibitors may alter levels. - Counsel women of childbearing potential: discuss risks and alternatives. - Store below 25°C: keep in the original pack, protect from moisture.

Lamotrigine can interact with several drugs, affecting its plasma concentration and safety profile.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising risk of severe rash. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels, requiring dose adjustment. - Other enzyme inducers (e.g., phenytoin, phenobarbital): can decrease lamotrigine exposure. - Serotonergic agents: monitor for additive central nervous system effects.